ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,131Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 823

$724K Total Retail Price of All Prescriptions

Rank: 57 out of 823

456 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

16% of this provider’s 456 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

2% of this provider’s 10,888 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $103 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
LISINOPRIL 472 365 1 4
FUROSEMIDE 424 380 2 7
OMEPRAZOLE 416 349 3 5
SIMVASTATIN 415 351 4 2
AMLODIPINE BESYLATE 407 330 5 3
LEVOTHYROXINE SODIUM 328 244 6 6
HYDROCODONE-ACETAMINOPHEN 313 255 S3 7 1
PRAVASTATIN SODIUM 268 238 8 23
METOPROLOL SUCCINATE 237 226 9 9
ALENDRONATE SODIUM 228 202 10 42
ATORVASTATIN CALCIUM 217 163 11 13
GABAPENTIN 216 145 12 8
METFORMIN HCL ER 206 166 13 94
ALLOPURINOL 193 192 14 61
CARVEDILOL 180 163 15 12
POTASSIUM CHLORIDE 178 155 16 22
HYDROCHLOROTHIAZIDE 166 110 17 29
METFORMIN HCL 155 115 18 14
NEXIUM 138 118 19 10
CRESTOR 138 110 19 20
DONEPEZIL HCL 135 134 21 24
SERTRALINE HCL 134 124 22 38
METOPROLOL TARTRATE 132 103 23 11
RISPERIDONE 121 121 24 78
MELOXICAM 120 101 25 27
KLOR-CON M20 118 115 26 198
RAMIPRIL 116 74 27 69
KLOR-CON M10 115 114 28 182
PREDNISONE 111 91 29 31
AMITRIPTYLINE HCL 106 75 R 30 89
WARFARIN SODIUM 106 83 30 18
PROAIR HFA 105 84 32 131
GLIPIZIDE 101 87 33 105
AMLODIPINE BESYLATE-BENAZEPRIL 99 73 34 81
TAMSULOSIN HCL 95 79 35 21
DIGOXIN 92 92 36 33
RANITIDINE HCL 89 62 37 74
TRAMADOL HCL 88 62 38 15
ZOLPIDEM TARTRATE 87 77 39 17
NAMENDA 86 86 40 28
NIFEDIPINE ER 81 55 41 97
CITALOPRAM HBR 77 53 42 34
ATENOLOL 77 51 42 47
PANTOPRAZOLE SODIUM 76 75 44 30
ISOSORBIDE MONONITRATE ER 75 75 45 49
LISINOPRIL-HYDROCHLOROTHIAZIDE 74 64 46 39
COMBIVENT 73 45 47 263
DIOVAN 72 72 48 35
SYNTHROID 72 72 48 37
POLYETHYLENE GLYCOL 3350 70 68 50 87
ADVAIR DISKUS 68 57 51 68
ACTONEL 68 68 51 228
LOSARTAN POTASSIUM 65 55 53 26
SINGULAIR 65 44 53 120
CLONIDINE HCL 65 38 53 41
SPIRIVA 64 62 56 64
FLUTICASONE PROPIONATE 63 54 57 50
OXYBUTYNIN CHLORIDE ER 63 59 57 178
ZETIA 61 49 59 100
ESCITALOPRAM OXALATE 60 60 60 99
CLOPIDOGREL 58 53 61 16
GLYBURIDE-METFORMIN HCL 58 46 R 61 121
TERAZOSIN HCL 58 58 61 269
IPRATROPIUM-ALBUTEROL 56 56 64 302
PLAVIX 56 56 64 25
CEFUROXIME 55 52 66 237
GLIMEPIRIDE 55 51 66 51
TRICOR 55 49 66 150
VENLAFAXINE HCL ER 54 34 69 163
MONTELUKAST SODIUM 52 37 70 192
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 29, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.